Actelion Ltd. Board Nominees Deny Sale is Main Aim

(Reuters) - A group of prospective Actelion board members denied speculation they planned to prepare Europe’s biggest biotech for sale and said they wanted instead to overhaul it.

MORE ON THIS TOPIC